drug store, pharmacy, chain drug store, drugstore, community pharmacy, drug chain, retail pharmacy




































































































































































































































INSIDE THIS ISSUE
News
Opinion
Other Services
Reprints / E-Prints
Submit News
White Papers

Supplier News Breaks Archives

Week of   


































































































































































































































































Week of Mon, Dec 27th, 2010

ECRM sheds light on retail promotions

ECRM has launched a series of reports and a blog that examine retail circular advertising.

Endo set to ship Fortesta testosterone gel

Endo Pharmaceuticals has obtained Food and Drug Administration clearance to market Fortesta Gel for topical use to treat men with low testosterone.

Impax to market generic Doryx

Impax Laboratories Inc. has received final approval from the Food and Drug Administration for 75-mg and 100-mg doxycyline hyclate delayed-release tablets, a generic version of the antibacterial medication Doryx.

Half of Frito-Lay product lineup to be all-natural

Frito-Lay North America plans to make about 50% of its product portfolio with all-natural ingredients and has begun shipping the first natural snacks to retailers.

Coty readies flurry of Sally Hansen launches

Coty Inc. is launching a wide range of Sally Hansen beauty implements and nail care products in the first quarter, including polish, polish strips, gel treatments and growth serum.

Sustainability strategy progresses at Nice-Pak

Nice-Pak Products Inc. has transformed its Mooresville, Ind., manufacturing plant into what it calls a “zero landfill” facility.

Cephalon names Buchi as CEO

Cephalon Inc. has appointed J. Kevin Buchi as chief executive officer and a member of the biopharmaceutical company's board.

Merck's Gardasil approved for new indications

Gardasil, Merck's vaccine for human papillomavirus (HPV), has been approved by the Food and Drug Administration for the prevention of anal cancer and anal intraepithelial neoplasia (AIN).

Advertisement